DIA – CMC Workshop
pharmafile | May 11, 2018 | News story | Medical Communications | dia
This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical arena.
Attendees from the different CMC (chemistry, manufacturing and controls) areas will be able to interact with peers from Regulatory Agencies and Industry in sessions enabling interactive cross-functional discussions.
The event will held on 20-21 June 2018 at the Radisson Blu in in Basel, Switzerland.
This program was developed by the CMC Working Group of the DIA Regulatory Affairs Community.
Who should attend?
Professionals involved in:
- CMC Regulatory Affairs
- CMC Writing
- Quality Assurance/Quality Control
- Regulatory Compliance
- API Development and Manufacturing
- Formulation Development and Manufacturing
- Analytical Development
- CMC Lifecycle Management
- CMC Project Management
Learning objectives
- Address technical challenges for biological and chemical molecules
- Discuss regulatory updates in a globalised environment
- Outline regulatory harmonisation initiatives
If you wish to attend, you can register here.
Related Content
DIA Value, Access, and Regulatory Conference 2018
Dr Solange Corriol-Rohou, Senior Director, Global Regulatory Affairs & Policy, Europe, at AstraZeneca Global Medicines …
DIA: Pharmacovigilance conference
We are in the midst of a breath-taking series of changes in the world of …